About Prudentia Sciences
Prudentia Sciences is a company based in Cambridge (United States) founded in 2023. Prudentia Sciences has raised $27 million across 2 funding rounds from investors including Google Ventures, Iaso Ventures and Virtue. Prudentia Sciences offers products and services including Prudentia Platform, Integrative Analytics, and Portfolio Optimization. Prudentia Sciences operates in a competitive market with competitors including Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prudentia
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27 M (USD)
in 2 rounds
-
Latest Funding Round
$20 M (USD), Series A
Jan 07, 2026
-
Investors
Google Ventures
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prudentia Sciences
Prudentia Sciences offers a comprehensive portfolio of products and services, including Prudentia Platform, Integrative Analytics, and Portfolio Optimization.
Platform for AI-driven asset diligence and valuation in drug development.
Tools for real-time simulation and risk assessment in biopharma investments.
AI-guided system for optimizing drug asset portfolios and deal strategies.
Funding Insights of Prudentia Sciences
Prudentia Sciences has successfully raised a total of $27M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prudentia Sciences
Prudentia Sciences has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Google Ventures, Iaso Ventures and Virtue.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital investments are made in healthcare innovation startups.
|
Locked | Locked | Locked | |
|
Pre-seed and seed-stage healthcare startups are funded by Virtue.
|
Locked | Locked | Locked |
Investor details for Prudentia Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prudentia Sciences
Investment portfolio details for Prudentia Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prudentia Sciences
Detailed financials for Prudentia Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prudentia Sciences Comparisons
Peer comparison for Prudentia Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prudentia Sciences
Prudentia Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal genomics is applied to healthcare advancements by Fauna Bio.
|
|
| Locked | Locked | Locked |
Data analytics and validation software for regulatory submission in the healthcare sector
|
|
| Locked | Locked | Locked |
AI-based drug discovery and clinical services are provided for biopharma.
|
|
| Locked | Locked | Locked |
AI-powered platforms for autonomous scientific research are developed.
|
|
| Locked | Locked | Locked |
Provider of clinical research data services for oncology & other therapeutic areas
|
Detailed competitors of Prudentia Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prudentia Sciences
Complete news archive for Prudentia Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prudentia Sciences
Prudentia Sciences was founded in 2023 and raised its 1st funding round 2 years after it was founded.
Prudentia Sciences is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Prudentia Sciences is a funded company, having raised a total of $27M across 2 funding rounds to date.
Provider of AI-powered drug asset diligence and valuation. This platform offers real-time data-driven simulation and scenario planning to optimize asset valuation for deal terms, enabling faster decision-making and increased deal throughput. It rapidly synthesizes data room information into an asset assessment framework and product profile, facilitating comparisons with public and proprietary data and benchmarks. The platform also provides AI-guided product profiles and asset valuations to guide portfolio strategy and decision-making, and includes multi-disciplinary expert-in-the-loop deal analysis and modeling with real-time analytics. The system features traceable AI, evidence-based insights, and robust security measures.
Prudentia Sciences's top competitors include Fauna Bio, Predxbio and Lila Sciences.
Prudentia Sciences offers Prudentia Platform, Integrative Analytics, and Portfolio Optimization.
Prudentia Sciences has 5 investors. Key investors include Google Ventures, Iaso Ventures, Virtue, McKesson Ventures, and SignalFire.